OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
Vincent G. Sorrentino, Srijan Thota, Edward A. Gonzalez, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 641-641
Open Access | Times Cited: 24
Vincent G. Sorrentino, Srijan Thota, Edward A. Gonzalez, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 641-641
Open Access | Times Cited: 24
Showing 24 citing articles:
Targeted Therapy Development in Acute Myeloid Leukemia
Tulasigeri M. Totiger, Anirban Ghoshal, Jenna Zabroski, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 641-641
Open Access | Times Cited: 22
Tulasigeri M. Totiger, Anirban Ghoshal, Jenna Zabroski, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 641-641
Open Access | Times Cited: 22
DNA methylation inhibitors adverse reaction characteristic analysis: an analysis based on the European spontaneous adverse event reporting system
Xia Zhang, Yuyu Liu, Qinming Hou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Xia Zhang, Yuyu Liu, Qinming Hou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
The Ataxia-telangiectasia mutated (ATM) is the most important gene for repairing the DNA in Myelodysplastic Neoplasm
Ronald Feitosa Pinheiro, João Vitor Caetano Goes, Letícia Rodrigues Sampaio, et al.
DNA repair (2025) Vol. 146, pp. 103803-103803
Closed Access
Ronald Feitosa Pinheiro, João Vitor Caetano Goes, Letícia Rodrigues Sampaio, et al.
DNA repair (2025) Vol. 146, pp. 103803-103803
Closed Access
Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies
Azar Tahghighi, Effat Seyedhashemi, Javad Mohammadi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Azar Tahghighi, Effat Seyedhashemi, Javad Mohammadi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Epigenetic Abnormalities in Chondrosarcoma
Michał Bereza, Mateusz Dembiński, Agnieszka Zając, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4539-4539
Open Access | Times Cited: 9
Michał Bereza, Mateusz Dembiński, Agnieszka Zając, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4539-4539
Open Access | Times Cited: 9
All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex
Lu Wang, Qi Zhang, Li Ye, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 4, pp. 691-701
Open Access | Times Cited: 11
Lu Wang, Qi Zhang, Li Ye, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 4, pp. 691-701
Open Access | Times Cited: 11
A High-Affinity Methyl-CpG-Binding Protein for Endonuclease-Free and Label-Free DNA Methyltransferase Activity Detection
Yang Bai, Shulin Tan, Yingsong Sheng, et al.
Journal of Analysis and Testing (2024) Vol. 8, Iss. 3, pp. 327-334
Closed Access | Times Cited: 1
Yang Bai, Shulin Tan, Yingsong Sheng, et al.
Journal of Analysis and Testing (2024) Vol. 8, Iss. 3, pp. 327-334
Closed Access | Times Cited: 1
Unifying targeted therapy for leukemia in the era of PARP inhibition
Liberalis Debraj Boila, Amitava Sengupta
Experimental Hematology (2023) Vol. 124, pp. 1-14
Closed Access | Times Cited: 3
Liberalis Debraj Boila, Amitava Sengupta
Experimental Hematology (2023) Vol. 124, pp. 1-14
Closed Access | Times Cited: 3
Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
Li Li, Ran Zhang, Weijie Cao, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 13, pp. 2113-2122
Closed Access | Times Cited: 2
Li Li, Ran Zhang, Weijie Cao, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 13, pp. 2113-2122
Closed Access | Times Cited: 2
Olsalazine pretreatment augments chemosensitivity of gemcitabine in hepatocellular carcinoma
Ayush Sharma, Abu Sufiyan Chhipa, Srashti Verma, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 6
Closed Access
Ayush Sharma, Abu Sufiyan Chhipa, Srashti Verma, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 6
Closed Access
Healthcare Utilization and Costs Among Patients with Acute Myeloid Leukemia Receiving Oral Azacitidine Maintenance Therapy Versus No Maintenance: A US Claims Database Study
Uma Borate, Karen Seiter, Ravi Potluri, et al.
Advances in Therapy (2024)
Open Access
Uma Borate, Karen Seiter, Ravi Potluri, et al.
Advances in Therapy (2024)
Open Access
A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation
Alex Y. Ge, Abolfazl Arab, Raymond Dai, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Alex Y. Ge, Abolfazl Arab, Raymond Dai, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Genetics and Molecular Pathogenesis of the Chondrosarcoma: A Review of the Literature
Georgian-Longin Iacobescu, Antonio-Daniel Corlatescu, Bogdan Șerban, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12658-12671
Open Access
Georgian-Longin Iacobescu, Antonio-Daniel Corlatescu, Bogdan Șerban, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12658-12671
Open Access
Gene Expression Profiles Identify Biomarkers of Resistance to Decitabine in Myelodysplastic Syndromes
Seungyoun Kim, Dong‐Yeop Shin, Dayeon Kim, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3494-3494
Open Access | Times Cited: 4
Seungyoun Kim, Dong‐Yeop Shin, Dayeon Kim, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3494-3494
Open Access | Times Cited: 4
Revolutionizing Non-Invasive Biomarker Discoveries: The Power of Methylation Screening Analysis in Cell-Free DNA Liquid Biopsy
Min Seob Lee, Na Young Min, Hyuk Jung Kwon, et al.
Open Journal of Genetics (2023) Vol. 13, Iss. 01, pp. 48-74
Open Access | Times Cited: 1
Min Seob Lee, Na Young Min, Hyuk Jung Kwon, et al.
Open Journal of Genetics (2023) Vol. 13, Iss. 01, pp. 48-74
Open Access | Times Cited: 1
Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer
Fabián Arechavaleta-Velasco, Pablo Domínguez-López, Ernesto Acosta-Jimenez, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 8, pp. 6863-6870
Open Access | Times Cited: 1
Fabián Arechavaleta-Velasco, Pablo Domínguez-López, Ernesto Acosta-Jimenez, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 8, pp. 6863-6870
Open Access | Times Cited: 1
Development and Validation of Stability Indicating RP-HPLC Method and Characterization of Degradation Products of Anti-neoplastic Agent by LCMS-MS
K. Anusha, Sowjanya Gummadi
International Journal of Pharmaceutical Quality Assurance (2023) Vol. 14, Iss. 04, pp. 867-873
Open Access | Times Cited: 1
K. Anusha, Sowjanya Gummadi
International Journal of Pharmaceutical Quality Assurance (2023) Vol. 14, Iss. 04, pp. 867-873
Open Access | Times Cited: 1
Decitabine as a Latency Perturbing Agent in Epstein-Barr Virus (EBV) Positive Natural Killer/T-Cell Lymphoma (NKTL)
Wang Liang Wei, Chin Jung Ee, Lee Jie Ying, et al.
(2022), pp. 485-495
Closed Access | Times Cited: 2
Wang Liang Wei, Chin Jung Ee, Lee Jie Ying, et al.
(2022), pp. 485-495
Closed Access | Times Cited: 2
Methylation of SPRED1: A New Target in Acute Myeloid Leukemia
Nan Su, Yujiao Wang, Xianglan Lu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Nan Su, Yujiao Wang, Xianglan Lu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer
Fabián Arechavaleta-Velasco, Pablo Domínguez-López, Ernesto Acosta-Jimenez, et al.
Research Square (Research Square) (2023)
Open Access
Fabián Arechavaleta-Velasco, Pablo Domínguez-López, Ernesto Acosta-Jimenez, et al.
Research Square (Research Square) (2023)
Open Access
Anti-CD47 antibodies: A potential new cancer immunotherapy
Da‐Liang Ou, Cheng-Zhe Jian, Guan-Sian Low, et al.
Journal of Cancer Research and Practice (2023) Vol. 10, Iss. 3, pp. 85-85
Open Access
Da‐Liang Ou, Cheng-Zhe Jian, Guan-Sian Low, et al.
Journal of Cancer Research and Practice (2023) Vol. 10, Iss. 3, pp. 85-85
Open Access
Genes diferencialmente expressos após a indução da hemoglobina fetal pela decitabina
Ingrid Grazielle Sousa
(2023)
Open Access
Ingrid Grazielle Sousa
(2023)
Open Access
Epigenetic therapy and DNA damage response
Marina Baretti, Nilofer S. Azad
Elsevier eBooks (2022), pp. 227-252
Closed Access
Marina Baretti, Nilofer S. Azad
Elsevier eBooks (2022), pp. 227-252
Closed Access
A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation
Alex Y. Ge, Abolfazl Arab, Raymond Dai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Alex Y. Ge, Abolfazl Arab, Raymond Dai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
